BlackRock Inc. - SUNESIS PHARMACEUTICALS INC ownership

SUNESIS PHARMACEUTICALS INC's ticker is SNSS and the CUSIP is 867328601. A total of 98 filers reported holding SUNESIS PHARMACEUTICALS INC in Q1 2014. The put-call ratio across all filers is 0.45 and the average weighting 0.1%.

Quarter-by-quarter ownership
BlackRock Inc. ownership history of SUNESIS PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2015$3,0000.0%1,2200.0%0.00%
Q4 2014$3,000
-66.7%
1,2200.0%0.00%
Q3 2014$9,000
+12.5%
1,2200.0%0.00%
Q2 2014$8,000
+33.3%
1,220
+26.7%
0.00%
Q1 2014$6,000
+20.0%
9630.0%0.00%
Q4 2013$5,0000.0%9630.0%0.00%
Q3 2013$5,0000.0%9630.0%0.00%
Q2 2013$5,0009630.00%
Other shareholders
SUNESIS PHARMACEUTICALS INC shareholders Q1 2014
NameSharesValueWeighting ↓
GREAT POINT PARTNERS LLC 8,250,000$7,404,0003.11%
BVF INC/IL 4,777,381$4,288,0000.73%
NEA Management Company, LLC 7,789,644$7,011,0000.45%
Palo Alto Investors LP 6,974,854$6,260,0000.35%
Healthcare Value Capital, LLC 150,000$135,0000.22%
Frontier Wealth Management LLC 527,870$474,0000.08%
DRIEHAUS CAPITAL MANAGEMENT LLC 2,067,122$1,855,0000.06%
Baker Brothers Advisors 4,450,000$3,994,0000.03%
Noven Financial Group, Inc. 41,000$37,0000.03%
FRANKLIN STREET ADVISORS INC /NC 100,000$90,0000.02%
View complete list of SUNESIS PHARMACEUTICALS INC shareholders